Literature DB >> 24325275

Pathogenicity of two Toxoplasma gondii strains in chickens of different ages infected via intraperitoneal injection.

Shuai Wang1, GuangWei Zhao, Wang Wang, Qing Xie, Meng Zhang, Cheng Yuan, Ibrahim Adam Hassan, XinChao Liu, LiXin Xu, RuoFeng Yan, XiaoKai Song, XiangRui Li.   

Abstract

This experiment was conducted to investigate the pathogenicity of Toxoplasma gondii in broilers of different ages. Chickens at the ages of 7, 14, 21 and 28 days were injected intraperitoneally with 1 × 10(8) tachyzoites of RH and JS strains of T. gondii, respectively. The clinical signs and death of chickens were recorded daily post inoculation. Serum samples were collected at days 0, 4, 11, 18, 25, 32, 39, 46 and 53 post infection to screen T. gondii circulating antigens (TCA) and T. gondii circulating antibodies (TCAb). The results showed that T. gondii infection of 7-day-old chickens caused death, even though the mortality rate of the JS strain (100%) was significantly higher than that of the RH strain (70%). Chickens at 14 days old showed only mild clinical signs, but no death. Neither clinical signs nor death were recorded in 21-day-old and 28-day-old chickens. TCA and TCAb became positive at days 4 and 11, respectively. Both the TCA and the TCAb of groups 21 days old (RH strain) and 28 days old (both RH and JS strains) decreased to a negative level earlier than the other experimental groups. Specific T. gondii DNA was detected by polymerase chain reaction in chickens that survived in the 7-day-old group (RH strain) and in all infected chickens of groups 14 days old and 21 days old injected with both strains. In the groups injected at 28 days old, three samples (RH strain) and one sample (JS strain) were found negative. The results indicated that the age of the chicken was an important factor affecting the pathogenicity of T. gondii and that these two strains of T. gondii displayed different virulence for chickens.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24325275     DOI: 10.1080/03079457.2013.874007

Source DB:  PubMed          Journal:  Avian Pathol        ISSN: 0307-9457            Impact factor:   3.378


  7 in total

Review 1.  Unifying Virulence Evaluation in Toxoplasma gondii: A Timely Task.

Authors:  Rafael Calero-Bernal; Mercedes Fernández-Escobar; Frank Katzer; Chunlei Su; Luis Miguel Ortega-Mora
Journal:  Front Cell Infect Microbiol       Date:  2022-04-28       Impact factor: 6.073

2.  Pathogenicity of Five Strains of Toxoplasma gondii from Different Animals to Chickens.

Authors:  Shuai Wang; Guang-Wei Zhao; Wang Wang; Zhen-Chao Zhang; Bo Shen; I A Hassan; Qing Xie; Ruo-Feng Yan; Xiao-Kai Song; Li-Xin Xu; Xiang-Rui Li
Journal:  Korean J Parasitol       Date:  2015-04-22       Impact factor: 1.341

3.  Toxoplasma gondii Elongation Factor 1-Alpha (TgEF-1α) Is a Novel Vaccine Candidate Antigen against Toxoplasmosis.

Authors:  Shuai Wang; Zhenchao Zhang; Yujian Wang; Javaid A Gadahi; Lixin Xu; Ruofeng Yan; Xiaokai Song; Xiangrui Li
Journal:  Front Microbiol       Date:  2017-02-13       Impact factor: 5.640

4.  Nano vaccines for T. gondii Ribosomal P2 Protein With Nanomaterials as a Promising DNA Vaccine Against Toxoplasmosis.

Authors:  ZhengQing Yu; Ke He; WanDi Cao; Muhammad Tahir Aleem; RuoFeng Yan; LiXin Xu; XiaoKai Song; XiangRui Li
Journal:  Front Immunol       Date:  2022-02-21       Impact factor: 7.561

5.  Toxoplasma gondii Proteasome Subunit Alpha Type 1 with Chitosan: A Promising Alternative to Traditional Adjuvant.

Authors:  Zhengqing Yu; Wenxi Ding; Muhammad Tahir Aleem; Junzhi Su; Junlong Liu; Jianxun Luo; Ruofeng Yan; Lixin Xu; Xiaokai Song; Xiangrui Li
Journal:  Pharmaceutics       Date:  2021-05-19       Impact factor: 6.321

6.  Protective immunity against acute toxoplasmosis in BALB/c mice induced by a DNA vaccine encoding Toxoplasma gondii elongation factor 1-alpha.

Authors:  Shuai Wang; YuJian Wang; XiaoNi Sun; ZhenChao Zhang; TingQi Liu; Javaid Ali Gadahi; Ibrahim Adam Hassan; LiXin Xu; RuoFeng Yan; XiaoKai Song; XiangRui Li
Journal:  BMC Infect Dis       Date:  2015-10-24       Impact factor: 3.090

7.  Immune Protection of Rhoptry Protein 21 (ROP21) of Toxoplasma gondii as a DNA Vaccine Against Toxoplasmosis.

Authors:  Zhenchao Zhang; Yuhua Li; Mingyong Wang; Qing Xie; Pengju Li; Suqiong Zuo; Lingmin Kong; Chenxing Wang; Shuai Wang
Journal:  Front Microbiol       Date:  2018-05-08       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.